Your browser doesn't support javascript.
loading
AI & experimental-based discovery and preclinical IND-enabling studies of selective BMX inhibitors for development of cancer therapeutics.
Elsanhoury, Rwan; Alasmari, Abdulaziz; Parupathi, Prashanth; Jumaa, Mouhannad; Al-Fayoumi, Suliman; Kumar, Avinash; Khashan, Raed; Nazzal, Sami; Fayyad, Ahmed Abu.
Afiliación
  • Elsanhoury R; Division of Pharmaceutical Sciences, Arnold and Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, NY, USA.
  • Alasmari A; Division of Pharmaceutical Sciences, Arnold and Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, NY, USA.
  • Parupathi P; Division of Pharmaceutical Sciences, Arnold and Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, NY, USA.
  • Jumaa M; Fekra Therapeutics Inc., Boston, MA, USA.
  • Al-Fayoumi S; Fekra Therapeutics Inc., Boston, MA, USA.
  • Kumar A; Division of Pharmaceutical Sciences, Arnold and Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, NY, USA.
  • Khashan R; Division of Pharmaceutical Sciences, Arnold and Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, NY, USA.
  • Nazzal S; College of Pharmacy, Texas Tech University Health Sciences Center, Dallas, TX, USA.
  • Fayyad AA; Division of Pharmaceutical Sciences, Arnold and Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, NY, USA. Electronic address: Ahmed.AbuFayyad@liu.edu.
Int J Pharm ; 645: 123384, 2023 Oct 15.
Article en En | MEDLINE | ID: mdl-37678472

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Int J Pharm Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Int J Pharm Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Países Bajos